SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-040702
Filing Date
2023-08-09
Accepted
2023-08-09 16:52:38
Documents
56
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q etnb-20230630.htm   iXBRL 10-Q 2452506
2 EX-31.1 etnb-ex31_1.htm EX-31.1 19252
3 EX-31.2 etnb-ex31_2.htm EX-31.2 19264
4 EX-32 etnb-ex32.htm EX-32 21084
  Complete submission text file 0000950170-23-040702.txt   8674109

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT etnb-20230630_lab.xml EX-101.LAB 464345
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT etnb-20230630_def.xml EX-101.DEF 186927
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT etnb-20230630.xsd EX-101.SCH 51007
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT etnb-20230630_pre.xml EX-101.PRE 321155
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT etnb-20230630_cal.xml EX-101.CAL 52812
50 EXTRACTED XBRL INSTANCE DOCUMENT etnb-20230630_htm.xml XML 1646698
Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39122 | Film No.: 231155978
SIC: 2834 Pharmaceutical Preparations